NEW YORK--(BUSINESS WIRE)--Levi & Korsinsky commences an investigation into the Board of Directors of Foundation Medicine, Inc. (“Foundation Medicine” or “the Company”) (NasdaqGS:FMI) for possible breaches of fiduciary duty and other violations of state law in connection with the sale of a majority stake in the Company to Roche Holding.
Click here to learn more about the investigation: http://zlk.9nl.com/foundation-medicine-fmi.
Under the terms of agreement, Roche will purchase approximately 15.6 million shares of Foundation Medicine at $50.00 per share and will then make a $250.0 million investment in the Company by purchasing 5.0 million newly issued shares of Foundation Medicine at the same price. The investigation concerns whether the consideration to be paid is adequate, and whether Foundation Medicine is acting in shareholders’ best interest by agreeing to the transaction.
If you own Foundation Medicine common stock and wish to obtain additional information, please contact Joseph E. Levi, Esq. either via email at jlevi@zlk.com or by telephone at (212) 363-7500, toll-free: (877) 363-5972, or visit http://zlk.9nl.com/foundation-medicine-fmi.
Levi & Korsinsky is a national firm with offices in New York, New Jersey, Connecticut and Washington D.C. The firm’s attorneys have extensive expertise in prosecuting securities litigation involving financial fraud, representing investors throughout the nation in securities and shareholder lawsuits. For more information, please feel free to contact any of the attorneys listed below. Attorney advertising. Prior results do not guarantee similar outcomes.
